C4 Therapeutics (CCCC) Profit After Tax: 2019-2025
Historic Profit After Tax for C4 Therapeutics (CCCC) over the last 6 years, with Sep 2025 value amounting to -$32.2 million.
- C4 Therapeutics' Profit After Tax fell 30.41% to -$32.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$119.1 million, marking a year-over-year decrease of 12.87%. This contributed to the annual value of -$105.3 million for FY2024, which is 20.52% up from last year.
- As of Q3 2025, C4 Therapeutics' Profit After Tax stood at -$32.2 million, which was down 23.62% from -$26.0 million recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Profit After Tax registered a high of -$15.7 million during Q4 2021, and its lowest value of -$37.2 million during Q4 2022.
- For the 3-year period, C4 Therapeutics' Profit After Tax averaged around -$29.3 million, with its median value being -$28.4 million (2024).
- As far as peak fluctuations go, C4 Therapeutics' Profit After Tax crashed by 137.52% in 2022, and later soared by 50.68% in 2024.
- Over the past 5 years, C4 Therapeutics' Profit After Tax (Quarterly) stood at -$15.7 million in 2021, then tumbled by 137.52% to -$37.2 million in 2022, then grew by 6.58% to -$34.8 million in 2023, then rose by 0.54% to -$34.6 million in 2024, then slumped by 30.41% to -$32.2 million in 2025.
- Its Profit After Tax stands at -$32.2 million for Q3 2025, versus -$26.0 million for Q2 2025 and -$26.3 million for Q1 2025.